Srs Capital Advisors, Inc. Axogen, Inc. Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Axogen, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 220 shares of AXGN stock, worth $3,832. This represents 0.0% of its overall portfolio holdings.
Number of Shares
220
Previous 173
27.17%
Holding current value
$3,832
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AXGN
# of Institutions
179Shares Held
36.2MCall Options Held
82.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN4.51MShares$78.5 Million7.26% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$56.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$51.5 Million3.39% of portfolio
-
Morgan Stanley New York, NY2.43MShares$42.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$42.3 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $737M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...